Volume 27, Issue 3 p. 319-328
ORIGINAL ARTICLE
Full Access

Primary Care Clinicians’ Perspectives on Management of Skin and Soft Tissue Infections: An Iowa Research Network Study

Jeanette M. Daly RN, PhD

Jeanette M. Daly RN, PhD

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author
John W. Ely MD, MSPH

John W. Ely MD, MSPH

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Barcey T. Levy PhD, MD

Barcey T. Levy PhD, MD

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Tara C. Smith PhD

Tara C. Smith PhD

Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Mary L. Merchant RN, PhD

Mary L. Merchant RN, PhD

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author
George R. Bergus MD

George R. Bergus MD

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author
Gerald J. Jogerst MD

Gerald J. Jogerst MD

Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Search for more papers by this author

Funding for this research was from the Agency for Healthcare Quality and Research, HHSA2902007100121.

The authors acknowledge the participation of the IRENE family physician offices—Family Medicine Clinic, Le Mars, Iowa; Family Medicine Associates, PC, Guttenberg, Iowa; Genesis Family Medicine, Davenport and Blue Grass, Iowa; Regional Family Health, Manchester, Iowa; The Country Doctor, Bloomfield, Iowa; Urbandale Family Physicians, Urbandale, Iowa; and the University of Iowa Health Care River Crossing, Riverside, Iowa. For further information, contact: Jeanette M. Daly, RN, PhD, 01290-F PFP, 200 Hawkins Drive, Iowa City, IA 52242; e-mail [email protected].

Abstract

An estimated 95,000 people developed methicillin-resistant Staphylococcus aureus (MRSA) infections during 2005 of which 14% were community-associated and 85% were hospital or other health setting associated, and 19,000 Americans died from these infections that year.

Purpose: To explore health care providers’ perspectives on management of skin and soft tissue infections to gain a better understanding of the problems faced by busy providers in primary care settings.

Methods: Focus group meetings were held at 9 family physician offices in the Iowa Research Network. Seventy-eight clinicians including physicians, nurses, nurse practitioners, and house officers attended. Meeting audiotapes were transcribed and coded by 3 investigators, and a MRSA-management taxonomy was developed.

Findings: The main themes that emerged from the focus groups included epidemiology, diagnosis, treatment, management, prevention, special populations, and public relations. The incidence of MRSA infections was perceived to have increased over the past decade. However, diagnosis and treatment protocols for physicians in the outpatient setting have lagged behind, and no well-accepted diagnostic or treatment algorithms were used by physicians attending the focus groups.

Conclusion: The clinicians in this study noted considerable confusion and inconsistency in the management of skin and soft tissue infections, particularly those due to MRSA.

Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to several commonly used antibiotics other than methicillin, such as oxacillin, penicillin, and amoxicillin. An estimated 95,000 people in the United States developed MRSA infections during 2005 of which 14% were community-associated and 85% were hospital or other health setting associated, and 19,000 Americans died from MRSA infections that year.1 The prevalence of the community-acquired infections in persons without established risk factors for MRSA has increased rapidly over the past decade.2,3 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has the potential to develop quickly from a localized abscess into an invasive infection requiring hospital admission, and it can lead to severe complications such as sepsis and necrotizing pneumonia.4,5

Antibiotic resistance to Staphylococcal infections has increased dramatically over the past 3 decades, from 2% in 1972,6 to 20%-25% in the early 1990s,7 to 63% by 2004.6 Staphylococcal infections, including MRSA, occur most frequently among persons in hospitals and health care facilities (such as nursing homes and dialysis centers) who have weakened immune systems. These are known as health care-associated (HA-MRSA). MRSA infections acquired by persons who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are classified as CA-MRSA infections.8 CA-MRSA infections are usually manifested as skin infections, such as pustules and abscesses, and often occur in otherwise healthy people. A third type of MRSA, livestock-associated MRSA (LA-MRSA), has also been identified.9

Health care is often less available in rural areas than it is in urban areas. Although rural areas include approximately 25% of the US population, they include only 10% of the nation's physicians despite having more health problems per capita.10 Risk factors that may contribute to greater health problems in rural areas include old age, low income levels, less employer-provided health care coverage, and greater transportation difficulties reaching health care providers.11 Rural residents tend to be poorer, which impacts on their receiving medical care.10 Recent data show that Americans visit physicians approximately 12 million times each year for suspected Staphylococcal skin infections.12 Since most CA-MRSA infections are managed initially on an outpatient basis, it is challenging for primary care clinicians to recognize and appropriately treat patients suspected of having such infections. The purpose of this study was to explore health care providers’ perspectives on the management of skin and soft tissue infections to gain a better understanding of the problems faced by busy primary care providers. We completed a qualitative analysis of focus group discussions involving family physician providers and their office staff. This study was also designed to learn about the tools that might be helpful to clinicians dealing with possible CA-MRSA infections.

Methods

The research team implemented a qualitative study using focus group meetings with physicians and staff from 9 different Iowa family physician offices. All but one office were private family physician offices; one was a residency training site. The residency training site has 2 locations in an urban and rural setting. The Institutional Review Board of the University of Iowa approved the project.

Subject Recruitment

We invited 302 family physicians, members of the of the Iowa Research Network (IRENE), a practice-based research network, to submit letters of support indicating they were potentially interested in participating in this study. We received letters of support from 43 physicians. After the proposal was funded, we notified those 43 IRENE physicians, provided them with a description of the study, and invited them to participate. Of the 43 invited physicians, 21 physicians from 20 different offices indicated interest and we selected 9 offices for the final sample based on serving a rural community. Each office was contacted and a focus group meeting with clinician providers and office staff was arranged at the office's convenience. During this time when arrangements were being made, 1 rural office pulled out of the study and no other office accepting to participate was rural, so the Urbandale office offered to participate. All focus groups were led by 1 of the investigators using a prepared set of open- and closed-ended prompts. Two investigators (one a family physician) conducted and audio-taped the focus group meetings, which lasted an hour. The tapes were transcribed and 3 investigators (JD, JE, and BL) reviewed the transcripts and developed a taxonomy of issues raised during the sessions (See Table 1).

Table 1. MRSA Taxonomy (Qualitative Analysis Codebook)
1. Epidemiology (Epidemiologic issues related to MRSA and other soft tissue infections)
 1.1. Risk factors (Etiology, cause. Issues related to risk factors for MRSA)
  1.1.1. Unexplained (The occurrence of MRSA is often unexplained and often no risk factors can be identified)
  1.1.2. Wrestling/Athletics (Wrestling is a risk factor for MRSA. Athletic participation as a risk for MRSA)
  1.1.3. Age group (Age groups most commonly involved. Children are at increased risk)
  1.1.4. Antibiotic use (The general increased used of antibiotics may be responsible for the emergence of MRSA in this community)
  1.1.5. Farm exposures (Farm exposures are a risk for MRSA)
  1.1.6. Nursing homes/group homes (Nursing homes, group homes, and long-term care facilities are a risk for MRSA)
  1.1.7. Meat packing (Meat packing plants are a risk for MRSA)
  1.1.8. Recurrent infections (Recurrent soft tissue infections are a risk for MRSA)
  1.1.9. Immune system (Issues related to the immune system and immunocompromise and diabetes as risk factors)
  1.1.10. Spider bite (infection is red, swollen sore, and mimics a spider bite)
  1.1.11. Contacts (Household or group home or other close contacts with MRSA are a risk for MRSA)
  1.1.12. Military (Being in the military is a risk for MRSA)
  1.1.13. Seasonal (The season of the year can affect the incidence of MRSA)
  1.1.14. Socioeconomic group (Any comment about socioeconomic status as a risk factor)
  1.1.15. Wound appearance (Anything related to wound appearance or size of wound or presence of abscess as a risk for MRSA)
  1.1.16. Pain (Increased pain is a risk factor for MRSA)
  1.1.17. Sharing towels (Sharing towels is a risk factor)
  1.1.18. Compact (Women can get recurrent infections from using a contaminated compact)
  1.1.19. Hospitalization (Hospitalization is a risk factor for MRSA)
  1.1.20. Picking at wound (Picking at wound with fingernails is a risk factor)
  1.1.21. Injury (Accidental injury or assault or fighting is a risk factor for MRSA)
  1.1.22. CPAP (CPAP mask, especially if ill-fitting, is a risk factor for MRSA)
  1.1.23. Tattooing (Tattooing is a risk factor for MRSA)
 1.2. Incidence (Incidence of MRSA in the community. Incidence of soft tissue infections in the community. Also the proportion of cultures that are MRSA vs MSSA)
 1.3. Onset (Issues about the onset of the MRSA epidemic)
 1.4. Infection site (The site of the soft tissue infection)
 1.5. Infection type (Comments on how the infections manifest, such as abscess vs superficial skin infection, vs other)
2. Diagnosis (Diagnosis of MRSA)
 2.1. Quick MRSA (Referring to a rapid test for MRSA, like the rapid Strep test)
 2.2. Culture (Issues related to wound cultures)
  2.2.1. Problems obtaining cultures (Issues related to difficulty obtaining adequate material for culture)
  2.2.2. Problems interpreting cultures (Issues related to interpreting culture results or getting negative cultures)
  2.2.3. Indications for culture (Indications for getting a culture)
  2.2.4. Culture results (Information provided in culture report)
 2.3. Differential diagnosis (Differential diagnosis of MRSA infections)
  2.3.1. Hospital-acquired vs community-acquired MRSA (It can be difficult to know whether the MRSA was hospital or community acquired and the distinction can be blurred)
  2.3.2. Other organisms (Other organisms that can cause soft tissue infections, such as Strep, fungus, chickenpox, Pseudomonas)
 2.4. Appearance (Making a diagnosis of MRSA vs no MRSA on the basis of appearance of the lesion)
3. Treatment (MRSA treatment issues)
 3.1. Antibiotic treatment (Issues related to antibiotic treatment of MRSA)
  3.1.1. Initial antibiotic (Initial antibiotic choice before culture results are known)
  3.1.1.1. Initial antibiotic—MSSA (Initial antibiotic when MSSA suspected)
  3.1.1.2. Initial antibiotic—MRSA (Initial antibiotic when MRSA suspected)
  3.1.2. Indications for antibiotics (When are any antibiotics indicated for soft tissue infections)
  3.1.3. Multiple vs single antibiotic (Should a single antibiotic be used to treat MRSA or should multiple antibiotics be used)
  3.1.4. Antibiotic dose (Issues related to the dose of antibiotics)
  3.1.5. Compliance (Patient compliance with full course of antibiotics. Patients don't always take the full course. Also compliance with wound care instructions)
  3.1.6. Drug costs (The influence of drug cost on antibiotic selection)
  3.1.7. Side effects (Adverse effects of antibiotics)
  3.1.8. Antibiotic ointment (Use of antibiotic ointment for soft tissue infection)
  3.1.9. Pregnancy (Antibiotic issues related to pregnancy and lactation)
 3.2. Incision and drainage (Issues related to the operative treatment of soft tissue infections, specifically incision and drainage)
  3.2.1. Packing (Issues related to packing the wound, type of packing material, frequency of packing changes)
  3.2.2. Equipment (Instruments, packing material, dressings, I&D kits, component of kits used to perform incision and drainage)
  3.2.3. Anesthesia for I&D (Issues related to anesthesia and sedation before incision and drainage)
  3.2.4. Surgeon (Issues about surgical referral)
  3.2.5. Setting (Where I&D is done; eg, clinic vs OR)
  3.2.6. Indications for I&D (Indications for I&D)
  3.2.7. Skin prep (How is the skin prepped before doing an I&D)
  3.2.8. Wound care (Self-care of wound at home after I&D)
  3.2.9. Location (Location of abscess as it affects decisions about I&D)
 3.3. Follow-up (When should patients be seen back after their initial visit. Trouble getting patients back in for follow-up)
 3.4. Seeking care (The patient's decision to seek care for their soft tissue infection)
  3.4.1. Prompt (What prompted the patient to seek medical care?)
  3.4.2. Timing (How long patient waits before seeking care)
 3.5. Unresponsive (Infections unresponsive to initial treatment)
 3.6. Decolonization (Staph decolonization in chronic carriers and families)
 3.7. Nonantibiotic local treatment (eg, soaks, iodine)
4. Management (Patient care issues that include both diagnosis and treatment or that do not specify diagnosis or treatment and could refer to either or both)
 4.1. Clinic protocol (In which rooms to see patients with MRSA, room cleaning, etc.)
 4.2. Economics (Patient's ability to pay for care)
 4.3. Work (Work restrictions imposed by employers of patients with MRSA)
 4.4. Ethics (Ethical issues related to management of MRSA)
 4.5. Management strategy (Algorithms and guidelines that include aspects of both diagnosis and treatment)
 4.6. Patient education
 4.7. Future (Providers’ suggestions for improving care of MRSA infections in the future)
 4.8. Practical (What management strategies are practical in the community?)
 4.9. Photographs (Taking photographs of lesions)
5. Prevention (Prevention of MRSA infections)
 5.1. Prevention in wrestlers (How to prevent MRSA in wrestlers)
 5.2. Overuse of antibiotics
6. Special Populations (Any aspect of MRSA as it relates to special populations—eg, epidemiology, prognosis, diagnosis, treatment, prevention)
 6.1. Children (Differences in children)
 6.2. Low socioeconomic status (Differences in low SES patients)
 6.3. Amish (Differences among the Amish)
 6.4. Dark skin (Differences in patients with dark skin)
7. Public relations (Any aspect of public relations including public media)
8. Other relevant comments

Focus Group Questions

To help facilitate the focus group discussions, the investigators generated 13 questions related to the epidemiology and office management of CA-MRSA (See Table 2). The questions were developed and refined by the investigators during a series of research team meetings. Once a near final set of questions was determined, these questions were pilot tested on a group of 5 family medicine faculty and research assistants at the University of Iowa. The questions were further revised following this pilot session.

Table 2. Focus Group Questions for Office Site Visit
 1. Has the frequency of skin and soft tissue infections changed in your community within the past year? In what way?
 2. Is community-associated MRSA a problem in your community?
 3. What are the patient risk factors that you look for when you evaluate a patient's risk of community-associated MRSA?
 4. Have you been able to determine a source for the CA-MRSA infections that you have seen?
   - If yes, what are the sources of the CA-MRSA infections that you have seen? (eg, athletic injuries, insect bites, farm injuries, etc.)
 5. About how many patients with CA-MRSA has your office managed in the past 6 months?
 6. What difficulties have you encountered in managing patients with skin and soft tissue infections?
 7. Are there particular difficulties with managing infections due to community-associated MRSA?
 8. What suggestions do you have for implementing systematic approaches to managing community-associated MRSA in your office?
 9. Describe your current management for a patient with a skin or soft tissue infection:
   - How often are wounds packed?
   - What type of gauze is used for packing?
   - Do you routinely prescribe antibiotics following incision and drainage? If so, which antibiotic(s)?
10. Do you routinely perform I&D on children?
   - Do you use pediatric sedation if needed?
   - Describe medication used and monitoring for sedation
11. Do you have other comments about children with infections?
12. Are children typically referred for I&D?
   - Describe specialty of physician to whom children are referred and where they’re treated?
13. Asked for input on what might constitute a “best practices” approach for managing patients with skin and soft tissue infections, as well as patients suspected of having community-associated MRSA.

Focus Group Meetings

Focus group meetings were arranged by a study investigator with the office administrator or physician interested in the study. A study physician and research assistant traveled to each site and conducted the meeting at a time convenient for the office, usually the noon hour, and lunch was provided. Two tape recorders were arranged at each end of the meeting place to record all conversations. Everyone seemed willing to participate and share information. Similar responses to the questions were noted from both the rural and urban sites.

Qualitative Analysis

A multistep process was used to identify the core themes that represented the perceptions of nurses, nurse practitioners, physicians, physician assistants, and family medicine residents (at the single residency training site) about the management of CA-MRSA.13,14 All transcriptions were analyzed using ATLAS.ti (Scientific Software Development GmbH, Berlin, Germany, http://www.atlasti.com), a qualitative software program that allows for coding and systematic searching of data. After development of a preliminary codebook, initial coding was conducted by the investigators (JD, JE, and BL) to identify general themes in the transcripts. The 3 investigators added extensively to the original codebook as additional transcripts were reviewed until saturation was obtained. Codes were then grouped into underlying themes after discussion among the investigators.

Results

Focus group meetings were held with physicians and office staff from each of the 9 participating practices. A total of 78 clinicians (nurses, nurse practitioners, physicians, physician assistants, family practice residents, pharmacists) participated. The participating practices were mostly located in small Iowa towns: Bloomfield (2,601 population, 9 participants), Blue Grass (1,169 population), Davenport (98,359 population, 20 participants), Guttenberg (1,987 population, 6 participants), Le Mars (9,237 population, 5 participants), Lone Tree (1,151 population, 3 participants), Manchester (5,257 population, 24 participants), Sigourney (2,209 population, 6 participants), and Urbandale (29,072 population, 5 participants). The main themes that emerged from the focus groups were grouped into 7 broad categories: epidemiology, diagnosis, treatment, management, prevention, special populations, and public relations. Within these broad themes, the most frequently discussed items were the incidence of MRSA, initial antibiotic used, clinic protocol, and management strategy.

Epidemiology

The epidemiology category included incidence, risk factors, onset, infection site, and infection type. Overall, the participants agreed that the incidence of CA-MRSA is increasing, that they are seeing it in all age groups and especially those persons who are healthy.

“Three years ago we started having this [CA-MRSA]. But I think 6 months ago it really …”“Oh, yeah, it did spike then. But 3 years ago was when we started noticing it [CA-MRSA].”

The exact number of CA-MRSA infections was difficult to pinpoint across all offices.

“Well, we have 6 providers, and I don't know what the number would be for all 6 of us. I know, maybe a little more than I used to see, probably 5 or 6 a month, for myself.”“That's a handful, at the most.”“That's what I’d say, maybe 1 or 2 a week.”“OK, about 5 per month times 6 providers or so.”

Some risk factors were common across sites, such as participating in sports and sharing equipment, residing in a nursing home, impaired immune system, and recent hospitalization. However, most cases seemed to have none of the recognized risk factors.15

“I guess I see it [MRSA] in the people I wouldn't expect to see it in.”

“We see it in all socioeconomic groups.”

“It comes from all walks.”

However, some risk factors were only described at 1 office, such as tattooing, wearing a CPAP mask, and sharing a makeup compact.

“The 2 patients that I saw: 1 had, I think, tattoo-related etiology for onset, and the other had a razor burn.”

“CPAP masks seem to cause MRSA on the face.”

The infection site varied, such as under the arm or on the leg, no 1 infection site was apparent across offices. Infections were noted with either abscesses or cellulitis, or both. Onset varied from a few days to many days before a patient would present with symptoms.

“Because I have had some that come in, and they’ve been doctoring it at home, and it's just not getting better, not getting better. And they’ve maybe already tried the other antibiotics—like Neosporin topical—and they’re not working.”

Diagnosis

The diagnosis theme incorporated MRSA identification as well as signs and symptoms. Rapid testing for MRSA, cultures, differential diagnosis, and appearance were also discussed.

“They have a quick MRSA, so I will get that in 24 hours. But that has even been falsely negative, where they say, initially negative for MRSA, and then a couple of days later they fill it out [as MRSA].”

Physicians for the most part agreed if the abscess is fluctuant that a culture should be obtained and sent to the laboratory. At many offices, circumstances often prevented culturing and led to confusion about appropriate treatment. Problems encountered with culture included cultures not being taken when drainage was present, cultures not done because the patient had no insurance, no fluid present to take a culture, and cultures being taken after an antibiotic was prescribed and taken.

“We don't really have anything to culture. We treat, assuming that this might be MRSA.”

“It's tough when they go someplace else and they don't get cultured, and they don't get treated adequately, and they’re told, I can tell by looking this isn't MRSA.”

“There was a time a few years ago during my residency when the attitude among the residents was to suspect MRSA and treat with Bactrim empirically without incising and culturing. The problem I see with that is that I didn't know for sure if it was MRSA or not. So, the post-treatment instruction that I give—you know, I don't want to put everybody on chlorhexidine and bleach baths—so if I know it is MRSA by culturing it, I can do that. And also, it helps epidemiologically by becoming an important statistic.”

Discussion of the appearance of the infected site included many aspects, such as the size, color, presence of drainage, and inflammation. The participants noted that the more prominent the abscess as part of a cellulitis, the more likely they thought about it being CA-MRSA.

“We’re more concerned about MRSA when we see multiple abscesses in various stages of healing.”

“People come in and they have the red spot [MRSA].”

“And if you don't have an explanation, like a trauma or something that would have made them more at risk for infection. If it just comes on out of the blue, I guess we’d be thinking more that it might be MRSA.”

Treatment

This category included techniques or actions applied to infections or suspected infections. Participants discussed antibiotic treatment, incision and drainage, packing, follow-up care, seeking care, unresponsiveness to treatment, decolonization, and nonantibiotic local treatment.

“The whole gamut of treatment options, to me, is kind of a morass. I really don't know what I’m supposed to be doing always—I’m not sure anybody really knows. But, to me it's kind of hopeless to try to eradicate it, frankly, because if you got it once, I don't know why you wouldn't get it back again. I don't think people can live their lives putting gloves on their hands for protection. So, I look at it as kind of a hopeless battle, frankly.”

“If I suspect MRSA, I start them on antibiotics right after draining them, instead of waiting for systemic symptoms or immunosuppression or failure to respond to I&D.”

“Sometimes what happens is, they come in and you treat them with Cephalexin, expecting it to clear up. And it won't clear up, and then you culture them and find out it's MRSA—then you deal with that.”

Incising wounds was also commonly discussed.

“Sometimes it depends on the technique that is used to do the I&D, whether they just use a small puncture hole vs making an ellipse and actually taking off some of the surface. If you make a little puncture hole, I think you just about have to pack them, or they are going to close right up; then you are just going to re-form the abscess right away. I think it is better just to make the ellipse, then you have much less of a chance of that coming over the top and re-forming the abscess.”

Packing an incised wound varied depending on the size, fluctuance, and purulence. Plain gauze was commonly used, and iodoform gauze was used occasionally.

“Unless they have a really fluctuant abscess, I don't pack them. I just either cross them or stab them and culture it.”

“I tend to use the plain unless it is really inflamed. If it is really purile, then I might use the iodoform. My thought is that the iodoform can be a little caustic to viable tissue, so I tend to use it less.”

Participants had many doubts about whether and how to attempt decolonization in patients with MRSA infections.

“My understanding is that it can be pretty hard to decolonize …”

“About 2 years ago I had a family with 5 little kids … And about every year the little kids had MRSA …  with positive cultures in most of the kids and the parents. And 1 of the kids was sent down to the university … . And the recommendation was sulfa for a month for the full family, and chlorine baths. I think it was 1/4 cup of chlorine bleach in a bathtub full of water and soak for about 15 minutes. We did that, and there's been no problems in that family, and it's been 2 years.”

“Yes, once you are paranoid, then you have to really look for it. You tend to culture it, tend to take pictures, follow up. You have to call the patient: ‘How is the problem responding to the treatment we instituted? How are you with the decontamination procedures we recommended for the long term, like for a month or 6 months.’”

Management

The management category addressed issues that included both diagnosis and treatment or issues where this distinction was not easily identified. Participants discussed clinic protocol, the patient's ability to pay for care, ethics, management strategies, patient education, suggestions for improving the treatment of MRSA infections in the future, and photographing wounds.

Among the 9 offices, only 1 had a protocol for skin and soft tissue infections. This protocol included items such as having 1 room designated for skin and soft tissue infections, and that a person presenting to the office with an infection be roomed immediately instead of waiting in the waiting room. There was concern that some of the guidelines for health care providers are too cumbersome to be used regularly in practice.

“The office doesn't have a specific protocol that we’re following.”

“[The patient can go in] any room.”

“I was just reading a little folder about MRSA, and reading about how, golly, for patient information, you know, when you’re gonna change your dressing, put on your disposable gloves, take it off, put the gloves and the dressing in a baggie, zip it up and throw it away, put on new gloves—or, actually, wash your hands—then put on new gloves, then put the dressing on, then put those gloves in a baggie and throw them away. I just don't see that kind of level of care ever percolating into the community enough to make a difference. I mean, gee, if 90% of the people did that, maybe you could kind of snuff it out, but it doesn't take too many people being sloppy to re-spread it everywhere else. So I think it's kind of silly to give people advice like that if you don't really believe that they’re going [to] do it.”

However, some office staff were aware of MRSA problems and had the following comments:

“I would say treat the room between patients like every case is MRSA. We don't want patients coming in and getting MRSA here.”

“My staff is almost—well, I wouldn't call it—we aren't paranoid, but wiping down the counters and your phones, and they each have access to bottles that they can do that.”

Participants were given copies of the Centers for Disease Control (CDC) and UpToDate® algorithms for the management of skin and soft tissue infections.16,17 After reviewing the algorithms, some clinicians indicated this is what they are currently doing and others remained confused about the guidelines:

“This doesn't make any distinction between cellulitis and abscess.”

“It [the algorithm] assumes that you can make some clinical decision on MRSA, which I don't feel I have enough information to make.”

“That UpToDate form has some doses on it, whereas the CDC one does not.”

Ethical issues were discussed mainly concerning the patients’ ability to pay for services. Those services discussed were obtaining a culture or filling a prescription for antibiotics.

“I was taught in residency that you always follow the standard, and you let the patient decline that. You know they cannot pay, you still give them the standard. If they want to decline, they can decline. It is my job to give them that standard and give them that opportunity, and it is their job to say, ‘No, I cannot afford that.’”

A few doctors mentioned the cost of culturing being prohibitive for uninsured patients. Some treated patients without insurance differently, so there is a variation and lack of agreement on culturing.

“He didn't have insurance. Normally, I would have done a culture, but I didn't do the culture because of that.”

Prevention

The prevention category included overuse of antibiotics and cleaning athletic equipment and does overlap some of the management issues.

“They did some special cleaning in the locker rooms.”

“I think they [coaches] are a little more diligent once somebody gets something.”

“Find a drug that kills it—and quit using drugs for things that don't need antibiotics. That would probably be the best approach, and that's been worked on, and it's mighty hard to implement, but we’ve surely tried.”

Special Populations

The special populations category addressed aspects of MRSA management related to children, low socioeconomic status patients, and patients with dark skin.

“I probably wouldn't I&D them [a child]. I probably wouldn't be as likely to, just because of the discomfort you’re causing them.”

“Anybody [including children] that has an abscess gets an I&D.”

Public Relations

The public relations category dealt with any aspect of public relations including the media. Only 1 office discussed this issue.

“Why is the focus more intense? More publicity, or … .”

“That's part of it. You always hear ‘the flesh-eating bacteria.’ Is this the flesh-eating bacteria problem?”

Discussion

Most patients presenting to these physicians with CA-MRSA had none of the risk factors that have been noted,18,19 leading to the confusion of providers regarding treating patients without the known risk factor. In some cases, however, risk factors were noted, such as athletics, especially wrestling, and farm exposures. Physicians expressed frustration with the absence of clear guidelines on diagnosis and treatment. They noted that in many patients, there was no wound drainage to culture and wondered whether to initially treat for MRSA without the benefit of culture results. Physicians also found themselves deviating from usual practice in patients who could not afford cultures and in children who may be less tolerant of incision and drainage procedures.

Infections with MRSA have increased in community practices over the past decade.6-8 The prevalence of CA-MRSA nationwide is unknown since we know of no states that track this. Diagnosis and treatment protocols for physicians outside of the hospital have lagged behind institutional protocols, and no commonly accepted diagnostic or treatment algorithms were used by the physicians in our focus groups. The CDC published a report that summarizes 16 strategies for the clinical management of MRSA in the community. This report is accessible on the web, but for a busy clinician it would be difficult to find, time consuming to read in its entirety, and does not have an algorithm or easy to use page with treatment strategies.20 The clinicians freely admitted confusion about the best management and treatment of skin and soft tissue infections.

Management and treatment of skin and soft tissue infections were found to be different across primary care offices. However, similar themes across offices included the lack of an explanation for the cause of the infection, the common practice of incising and draining abscesses, and the lack of written instructions for wound care. The initial antibiotic choice varied across offices, and dedicated rooms for examination or treatment were infrequently employed. Concern by the clinicians was voiced that many recommended practices are simply not practical in the community setting.

Physicians and nurses expressed interest in using standard algorithms to help guide management of skin and soft tissue infections, but they were typically unaware of the existence of the algorithms released by the Centers for Disease Control and UpToDate.16,17 Additional education of physicians and ongoing research to develop diagnosis and treatment algorithms that take into account local antibiotic susceptibilities may help guide treatment of MRSA infections and prevent future infections in the community. The clinicians in this study acknowledged that liberal use of antibiotics may have contributed to the increased incidence of MRSA infections. Our findings are supported by previous studies that found that most patients with CA-MRSA have no identifiable risk factors, although potential risk factors include working in health care, having a previous MRSA infection, and being recently hospitalized.18,19 For example, in a study of New York high school football players, those who shared towels were at higher risk for MRSA infections.21 Our participants also felt that high school wrestlers and football players were at increased risk.

Limitations of this study include that a relatively small group of physicians from practices in a rural state were studied and the results may not be generalizable to other settings. The Davenport and Urbandale offices were located in fairly large towns rather than small office settings. Although our focus group questions were developed using an iterative process with faculty physicians actively involved in clinical care, some of the questions were closed-ended. However, participating physicians did not seem restricted by our questions and offered many opinions that were unrelated to our questions. For example, several physicians brought up the problems associated with decolonization, which we did not anticipate.

In conclusion, we found that practicing physicians face several issues that have been inadequately addressed by current guidelines:

  • -

    What risk factors should prompt suspicion of MRSA?

  • -

    What is the recommended initial antibiotic in patients with skin infections and no wound drainage for culture or in patients with unhelpful culture results (eg, “normal skin flora”)?

  • -

    How should treatment be modified for children?

  • -

    What packing material if any should be used for incision and drainage procedures?

  • -

    In patients who do not respond to initial antibiotics, what second-line antibiotics should be used?

  • -

    How should treatment be modified in patients with no insurance who cannot afford expensive cultures or antibiotics or drainage procedures?

Physicians in this study expressed an interest in following guidelines that address these issues more comprehensively, and they were open to standardization of practice in relation to MRSA, provided these guidelines accounted for practical issues that arise in the community. We recognize the lack of definitive evidence to support recommendations related to these practice-based problems and that more research may be needed. But in the absence of such research, physicians need better advice now to help them manage patients with skin and soft tissue infections. A guideline source that is easy to implement within the context of a busy practice setting would be appropriate, such as the CDC Treatment Algorithm for Skin and Soft Tissue Infections.16

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.